4//SEC Filing
Li Zhilin 4
Accession 0001013762-23-005114
CIK 0001106644other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 4:06 PM ET
Size
5.5 KB
Accession
0001013762-23-005114
Insider Transaction Report
Form 4
Li Zhilin
DirectorCEO & Interim CFO10% Owner
Transactions
- Award
Common Stock
2023-09-29$0.14/sh+13,757,063$1,925,989→ 15,138,063 total
Footnotes (2)
- [F1]On September 29, 2023, the reporting person was granted 13,757,063 shares of Issuer's common stock pursuant to certain loan settlement agreement with the Company to settle a loan in the amount of $1,854,452.10 that the Company owed to the reporting person.
- [F2]After giving effect to the 1-for-10 reverse stock split on March 6, 2023, resulting 13,810,000 shares the reporting person previously owned being 1,381,000 shares.
Documents
Issuer
CHINA PHARMA HOLDINGS, INC.
CIK 0001106644
Entity typeother
Related Parties
1- filerCIK 0001342188
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 4:06 PM ET
- Size
- 5.5 KB